Skip to main content
SpringerLink
Log in

Serum anti-Mullerian hormone levels correlate with ovarian response in idiopathic hypogonadotropic hypogonadism

  • ASSISTED REPRODUCTION TECHNOLOGIES
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

The role of serum AMH levels in prediction of ovarian response in idiopathic hypogonadotropic hypogonadism (IHH) was evaluated.

Material method(s)

Twelve patients with IHH underwent controlled ovarian hyperstimulation (COH) for IVF were enrolled in this prospective study. Serum AMH levels were studied on the 2nd or 3rd day of an induced menstrual cycle by a preceding low-dose oral contraceptive pill treatment. A fixed dose (150–300 IU/day) of hMG was given in all COH cycles. Correlations between serum AMH levels, COH outcomes and embryological data were investigated.

Results

Mean serum AMH levels was 3.47 ± 2.15 ng/mL and mean serum peak estradiol was 2196 ± 1705 pg/mL. Mean number of follicles >14 mm, >17 mm on hCG day and MII oocytes were 4.14 ± 3.2, 4 ± 2.5 and 7.28 ± 3.5, respectively. Mean number of grade A embryos and transferred embryos were 3.28 ± 2.4 and 2.5 ± 0.7, respectively. The clinical pregnancy rate per patient was 41.6 % (5/12). Positive correlations were observed between serum AMH levels and MII oocytes (r = 0.84), grade A embryos (r = 0.85), serum peak estradiol levels (r = 0.87), and number of follicles >14 mm (r = 0.83) and >17 mm (r = 0.81) on hCG day, respectively.

Conclusion

AMH appears as a promising marker of ovarian response in patients with IHH undergoing IVF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Arbo E, Vetori DV, Jimenez MF, Freitas FM, Lemos N, Cunha-Filho JS. Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills. Hum Reprod. 2007;22(12):3192–6.

    Article  PubMed  CAS  Google Scholar 

  2. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP, et al. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology. 1995;136:4951–62.

    Article  PubMed  CAS  Google Scholar 

  3. Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta analysis. Hum Reprod Update. 2011;17(1):46–54.

    Article  PubMed  CAS  Google Scholar 

  4. Burgués S, Spanish Collaborative Group on Female Hypogonadotrophic Hypogonadism. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Hum Reprod. 2001;16(12):2525–32.

    Article  PubMed  Google Scholar 

  5. Fisch JD, Rodriguez H, Ross R, Overby G, Sher G. The Graduated Embryo Score (GES) predicts blastocyst formation and pregnancy rate from cleavage-stage embryos. Hum Reprod. 2001;16(9):1970–5.

    Article  PubMed  CAS  Google Scholar 

  6. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91:4057–63.

    Article  PubMed  CAS  Google Scholar 

  7. La Marca A, Pati M, Orvieto R, Stabile G, Carducci Artenisio A, et al. Serum Anti-Mullerian Hormone levels in women with secondary amenorrhea. Fertil Steril. 2006;85:1547–9.

    Article  PubMed  Google Scholar 

  8. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Carducci A, et al. Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod. 2009;16(2):113–30.

    Google Scholar 

  9. Levy T, Orvieto R, Homburg R, Peleg D, Dekel A, Ben-Rafael Z. Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient. Hum Reprod. 1996;11(6):1177–9.

    Article  PubMed  CAS  Google Scholar 

  10. Luisi S, Ciani V, Podfigurna-Stopa A, et al. Serum anti-Müllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa. Gynecol Endocrinol. 2012;28(1):34–8.

    Article  PubMed  CAS  Google Scholar 

  11. Majumder K, Gelbaya TA, Laing I, Nardo LG. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur J Obstet Gynecol Reprod Biol. 2010;150(2):166–70.

    Article  PubMed  CAS  Google Scholar 

  12. Nakhuda GS, Douglas NC, Thornton MH, Guarnaccia MM, Lobo R, Sauer MV. Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors. Reprod Biomed Online. 2010;20(1):42–7.

    Article  PubMed  CAS  Google Scholar 

  13. Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, et al. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril. 2009;92:1586–93.

    Article  PubMed  CAS  Google Scholar 

  14. Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, et al. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009;24(4):867–75.

    Article  PubMed  CAS  Google Scholar 

  15. Panidis D, Georgopoulos NA, Piouka A, Katsikis I, Saltamavros AD, Decavalas G, et al. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia. Gynecol Endocrinol. 2010 Sep 14, [Epub ahead of print].

  16. Riggs R, Kimble T, Oehninger S, Bocca S, Zhao Y, Leader B, et al. Anti-Müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation. Fertil Steril. 2011;95:410–2.

    Article  PubMed  CAS  Google Scholar 

  17. Rothman MS, Wierman ME. Female hypogonadism: evaluation of the hypothalamic-pituitary-ovarian axis. Pituitary. 2008;11:163–9.

    Article  PubMed  Google Scholar 

  18. Somunkiran A, Yavuz T, Yucel O, Ozdemir I. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2007;134:196–201.

    Article  PubMed  CAS  Google Scholar 

  19. Speroff L, Fritz MA. Chapter 32, induction of ovulation. In: Speroff L, Fritz MA, editors. Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 1293–331.

    Google Scholar 

  20. Speroff L, Fritz MA. Chapter 11, amenorrhea. In: Speroff L, Fritz MA, editors. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 443.

    Google Scholar 

  21. Steiner AZ, Stanczyk FZ, Patel S, Edelman A. Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception. 2010;81(3):245–8.

    Article  PubMed  CAS  Google Scholar 

  22. Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril. 2008;90(2):395–400.

    Article  PubMed  CAS  Google Scholar 

  23. Sungurtekin U, Fraser IS, Shearman RP. Pregnancy in women with Kallmann’s Syndrome. Fertil Steril. 1995;63(3):494–9.

    PubMed  CAS  Google Scholar 

  24. Tran ND, Cedars MI, Rosen MP. The role of anti-müllerian hormone (AMH) in assessing ovarian reserve. J Clin Endocrinol Metab. 2011;96(12):3609–14.

    Article  PubMed  CAS  Google Scholar 

  25. Ulug U, Ben-Shlomo I, Tosun S, Erden HF, Akman MA, Bahceci M. The reproductive performance of women with hypo-gonadotropic hypogonadism in an in- vitro fertilization and embryo transfer program. J Assist Reprod Genet. 2005;22(4):167–71.

    Article  PubMed  Google Scholar 

  26. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groom NP, Visser JA, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77–83.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure statement

There are no financial or commercial interests to declare regarding the authors of the study.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Ankara University School of Medicine, Kadın Hastalıkları ve Dog AD, Cebeci, 06100, Ankara, Turkey

    M. Sönmezer, B. Özmen, C. S. Atabekoglu, E. G. Papuccu & B. Berker

  2. Ankara University Center for Research on Human Reproduction, Ankara, Turkey

    M. Sönmezer, B. Özmen, C. S. Atabekoglu, S. Ozkavukcu & B. Berker

  3. Department of Obstetrics and Gynecology, Ufuk University School of Medicine, Ankara, Turkey

    R. Pabuccu

Authors
  1. M. Sönmezer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Özmen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. S. Atabekoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. G. Papuccu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Ozkavukcu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Berker
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Pabuccu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Sönmezer.

Additional information

Capsule

AMH correlates with ovarian response in patients with idiopathic hypogonadotropic hypogonadism.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sönmezer, M., Özmen, B., Atabekoglu, C.S. et al. Serum anti-Mullerian hormone levels correlate with ovarian response in idiopathic hypogonadotropic hypogonadism. J Assist Reprod Genet 29, 597–602 (2012). https://doi.org/10.1007/s10815-012-9759-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-012-9759-1

Keywords

Search

Navigation